GE HealthCare Technologies Inc

We exclude from Segment EBIT certain corporate-related expenses and certain transactions or adjustments that our Chief Operating Decision Maker (which is our Chief Executive Officer) considers to be non-operational, such as Interest and other financial charges – net, Benefit (provision) for income taxes, restructuring costs, acquisition and disposition-related benefits (charges), Spin-Off and separation costs, Non-operating benefit (income) costs, gain (loss) on business and asset dispositions, amortization of acquisition-related intangible assets, Net (income) loss attributable to noncontrolling interests, Income (loss) from discontinued operations, net of taxes, and investment revaluation gain (loss). See Note 3, “Segment Information” for additional information on our reportable segments, and “Results of Operations” above for discussion on segment revenue performance.

•Imaging Segment EBIT was $199 million, an increase of $33 million due to cost productivity, growth in sales volume, and an increase in price, partially offset by unfavorable mix and increased investment;

•AVS Segment EBIT was $261 million, an increase of $4 million due to growth in sales volume and cost productivity largely offset by cost inflation;

•PCS Segment EBIT was $48 million, a decrease of $33 million due to increased investment, cost inflation, and unfavorable mix; and

•PDx Segment EBIT was $205 million, an increase of $27 million due to an increase in price and growth in sales volume, partially offset by increased investment.